AtriCure (ATRC)
(Real Time Quote from BATS)
$35.61 USD
+1.20 (3.49%)
Updated Aug 4, 2025 11:06 AM ET
3-Hold of 5 3
D Value A Growth A Momentum A VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/04/2025
Time: -- |
9/2025 | $-0.11 | 0.00% |
Earnings Summary
For their last quarter, AtriCure (ATRC) reported earnings of -$0.02 per share, beating the Zacks Consensus Estimate of $-0.15 per share. This reflects a positive earnings surprise of 86.67%. Look out for ATRC's next earnings release expected on November 04, 2025. For the next earning release, we expect the company to report earnings of -$0.11 per share, reflecting a year-over-year increase of 35.29%.
Earnings History
Price & Consensus
Zacks News for ATRC
AtriCure (ATRC) Reports Q2 Loss, Tops Revenue Estimates
ATRC: What are Zacks experts saying now?
Zacks Private Portfolio Services
Abbott (ABT) Q2 Earnings and Revenues Top Estimates
Has Amneal Pharmaceuticals (AMRX) Outpaced Other Medical Stocks This Year?
Are Medical Stocks Lagging Astellas Pharma (ALPMY) This Year?
ATRC FAQs
AtriCure, Inc. (ATRC) has announced they will report their next quarter earnings on November 04, 2025. For the next earning release, we expect the company to report earnings of $-0.11 per share, reflecting a year-over-year increase of 35.29%.
AtriCure, Inc. has announced they will report their previous quarter earnings after the close of the market on November 04, 2025.
The Zacks Consensus Estimate for AtriCure, Inc. (ATRC) for the quarter ending September 2025 is $-0.11 a share. We expect AtriCure, Inc. (ATRC) to report earnings in line with the consensus estimate of $-0.11 per share
In the earnings report for the quarter ending in September 2024, AtriCure, Inc. (ATRC) announced earnings of $-0.17 per share versus the Zacks Consensus Estimate of $-0.20 per share, representing a surprise of -15.00%.